153 related articles for article (PubMed ID: 35505144)
21. Earlier diagnosis of second primary melanoma confirms the benefits of patient education and routine postoperative follow-up.
DiFronzo LA; Wanek LA; Morton DL
Cancer; 2001 Apr; 91(8):1520-4. PubMed ID: 11301400
[TBL] [Abstract][Full Text] [Related]
22. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.
Herr MM; Schonfeld SJ; Dores GM; Withrow DR; Tucker MA; Curtis RE; Morton LM
J Natl Cancer Inst; 2018 Nov; 110(11):1248-1258. PubMed ID: 29659938
[TBL] [Abstract][Full Text] [Related]
23. Delay of Surgery for Melanoma Among Medicare Beneficiaries.
Lott JP; Narayan D; Soulos PR; Aminawung J; Gross CP
JAMA Dermatol; 2015 Jul; 151(7):731-41. PubMed ID: 25853865
[TBL] [Abstract][Full Text] [Related]
24. Types of second primary cancer influence overall survival in cutaneous melanoma.
Zheng G; Chattopadhyay S; Sundquist K; Sundquist J; Försti A; Hemminki A; Hemminki K
BMC Cancer; 2021 Oct; 21(1):1123. PubMed ID: 34663263
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological features of and risk factors for multiple primary melanomas.
Ferrone CR; Ben Porat L; Panageas KS; Berwick M; Halpern AC; Patel A; Coit DG
JAMA; 2005 Oct; 294(13):1647-54. PubMed ID: 16204664
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for second primary melanoma among Dutch patients with melanoma.
Schuurman MS; de Waal AC; Thijs EJM; van Rossum MM; Kiemeney LALM; Aben KKH
Br J Dermatol; 2017 Apr; 176(4):971-978. PubMed ID: 27596937
[TBL] [Abstract][Full Text] [Related]
27. Risk of Second Primary Cancer in Survivors of In Situ Melanoma.
Kimlin MG; Youlden DR; Brodie AM; DiSipio T; Youl P; Nair-Shalliker V; Baade PD
J Invest Dermatol; 2019 Apr; 139(4):842-847. PubMed ID: 30423330
[TBL] [Abstract][Full Text] [Related]
28. Disease progression in patients with thin cutaneous melanomas (tumour thickness < or = 0.75 mm): clinical and epidemiological data from the Tumour Center Munich 1977-98.
Schmid-Wendtner MH; Baumert J; Eberle J; Plewig G; Volkenandt M; Sander CA
Br J Dermatol; 2003 Oct; 149(4):788-93. PubMed ID: 14616371
[TBL] [Abstract][Full Text] [Related]
29. Second primary anal and oropharyngeal cancers in cervical cancer survivors.
Papatla K; Halpern MT; Hernandez E; Brown J; Benrubi D; Houck K; Chu C; Rubin S
Am J Obstet Gynecol; 2019 Nov; 221(5):478.e1-478.e6. PubMed ID: 31128108
[TBL] [Abstract][Full Text] [Related]
30. An association between cutaneous melanoma and non-Hodgkin's lymphoma: pooled analysis of published data with a review.
Lens MB; Newton-Bishop JA
Ann Oncol; 2005 Mar; 16(3):460-5. PubMed ID: 15642704
[TBL] [Abstract][Full Text] [Related]
31. Incidence of new primary melanomas after diagnosis of stage III and IV melanoma.
Zimmer L; Haydu LE; Menzies AM; Scolyer RA; Kefford RF; Thompson JF; Schadendorf D; Long GV
J Clin Oncol; 2014 Mar; 32(8):816-23. PubMed ID: 24297954
[TBL] [Abstract][Full Text] [Related]
32. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
33. Risk of second primary neoplasm and mortality in childhood cancer survivors based on a national registry database.
Hayek S; Dichtiar R; Shohat T; Silverman B; Ifrah A; Boker LK
Cancer Epidemiol; 2018 Dec; 57():127-133. PubMed ID: 30399484
[TBL] [Abstract][Full Text] [Related]
34. Incidence and characteristics of thick second primary melanomas: a study of the German Central Malignant Melanoma Registry.
Gassenmaier M; Stec T; Keim U; Leiter U; Eigentler TK; Metzler G; Garbe C
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):63-70. PubMed ID: 30051517
[TBL] [Abstract][Full Text] [Related]
35. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
[TBL] [Abstract][Full Text] [Related]
36. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study.
Friedman DL; Whitton J; Leisenring W; Mertens AC; Hammond S; Stovall M; Donaldson SS; Meadows AT; Robison LL; Neglia JP
J Natl Cancer Inst; 2010 Jul; 102(14):1083-95. PubMed ID: 20634481
[TBL] [Abstract][Full Text] [Related]
37. Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma.
Goggins WB; Finkelstein DM; Tsao H
Cancer; 2001 Feb; 91(4):874-80. PubMed ID: 11241258
[TBL] [Abstract][Full Text] [Related]
38. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
39. Survival disparities for second primary malignancies diagnosed among childhood cancer survivors: A population-based assessment.
Brown AL; Arroyo VM; Agrusa JE; Scheurer ME; Gramatges MM; Lupo PJ
Cancer; 2019 Oct; 125(20):3623-3630. PubMed ID: 31251393
[TBL] [Abstract][Full Text] [Related]
40. Melanoma as a subsequent neoplasm in adult survivors of childhood cancer: a report from the childhood cancer survivor study.
Pappo AS; Armstrong GT; Liu W; Srivastava DK; McDonald A; Leisenring WM; Hammond S; Stovall M; Neglia JP; Robison LL
Pediatr Blood Cancer; 2013 Mar; 60(3):461-6. PubMed ID: 22887858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]